Study Group: QT Interval Prolongation Experts (US)
Council Members in this Study Group: 64
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
- Evan Siegel
Adjunct Professor
THE UNIVERSITY OF QUEENSLAND
Evan Siegel, M Phil, Ph D, is the President and Chief Executive Officer of Ground Zero Pharmaceuticals, a regulatory affairs and product development consulting firm in California, since June 1999. Dr. Siegel is also an Adjunct Professor at the University...
Daniel WynnDirector, Clinical Research
CONSULTANTS IN NEUROLOGY LTDDaniel Wynn, MD, FACN, FAASM, is the Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 130 clinical trials in...
Eric GruffPrincipal
E4 ConsultingEric Gruff, PhD, MBA, BS, is the Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has 19 years of experience in the pharmaceutical and biotech sector, including...
- William Haynes
Director of Clinical Pharmacology
THE UNIVERSITY OF IOWAWilliam Haynes, MD, is Professor of Medicine and Director of Clinical Pharmacology at the University of Iowa. Dr. Haynes has expertise in cardiovascular risk factors including diabetes, hypertension, hyperlipidemia, obesity, and atherosclerosis. He has...
- Leo Pavliv
Senior Vice President, Operations
CUMBERLAND PHARMACEUTICALS, INC.Leo Pavliv, RPh, MBA, is a Senior Vice President of Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical...
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Consultancy, Pharma-Focused
- Pharmaceuticals Manufacturer
- Contract Research Organization, Independent/Small
- Office Based Private Practice or Clinic
- Academic Institution*
- Government/Military Hospital or Clinic
- Biotechnology Manufacturer
- Consultancy, Healthcare-Focused
- Pharmaceuticals/Biotechnology Research Services
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Physician - Director
- President
- Director
- Chief Executive Officer
- Chief Medical Officer
- Consultant
- Physician - Department Chair
- Physician - Division Head
- Owner
- Research Scientist
- Professor
- Research & Development Manager
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
October 26, 2006 | Palo Alto
GLGi: New Drug Application ProcessTeleconference: Multiple Sclerosis - Novel Therapies Under Development (3:30 PM EST/12:30 PM PST)
12/2/2010
Gerson Lehrman Group, Inc. connects communities with knowledge through two distinct, yet complementary offerings: GLG Research and G+.